BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16996553)

  • 1. The effect of capsid mutations on HIV-1 uncoating.
    Wacharapornin P; Lauhakirti D; Auewarakul P
    Virology; 2007 Feb; 358(1):48-54. PubMed ID: 16996553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells.
    Hulme AE; Kelley Z; Okocha EA; Hope TJ
    J Virol; 2015 Jan; 89(1):643-51. PubMed ID: 25339776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness.
    Sanchez-Merino V; Farrow MA; Brewster F; Somasundaran M; Luzuriaga K
    J Infect Dis; 2008 Jan; 197(2):300-8. PubMed ID: 18177249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoating of HIV-1 requires cellular activation.
    Auewarakul P; Wacharapornin P; Srichatrapimuk S; Chutipongtanate S; Puthavathana P
    Virology; 2005 Jun; 337(1):93-101. PubMed ID: 15882886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation in the loop C-terminal to the cyclophilin A binding site of HIV-1 capsid protein disrupts proper virus assembly and infectivity.
    Abdurahman S; Höglund S; Höglund A; Vahlne A
    Retrovirology; 2007 Mar; 4():19. PubMed ID: 17371591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.
    Briones MS; Dobard CW; Chow SA
    J Virol; 2010 May; 84(10):5181-90. PubMed ID: 20219923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
    Hulme AE; Kelley Z; Foley D; Hope TJ
    J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrostatic repulsion between HIV-1 capsid proteins modulates hexamer plasticity and in vitro assembly.
    Brun S; Chaloin L; Gay B; Bernard E; Devaux C; Lionne C; Chazal N; Briant L
    Proteins; 2010 Jul; 78(9):2144-56. PubMed ID: 20455269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection.
    Cartier C; Sivard P; Tranchat C; Decimo D; Desgranges C; Boyer V
    J Biol Chem; 1999 Jul; 274(27):19434-40. PubMed ID: 10383459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of N-terminal domain charged residues on the assembly and stability of HIV-1 CA.
    Douglas CC; Thomas D; Lanman J; Prevelige PE
    Biochemistry; 2004 Aug; 43(32):10435-41. PubMed ID: 15301542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects.
    Yang R; Shi J; Byeon IJ; Ahn J; Sheehan JH; Meiler J; Gronenborn AM; Aiken C
    Retrovirology; 2012 Apr; 9():30. PubMed ID: 22515365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.
    Shibata J; Yoshimura K; Honda A; Koito A; Murakami T; Matsushita S
    J Virol; 2007 Apr; 81(8):3757-68. PubMed ID: 17251298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the mechanical properties of wild type and hyperstable mutants of the HIV-1 capsid.
    Ramalho R; Rankovic S; Zhou J; Aiken C; Rousso I
    Retrovirology; 2016 Mar; 13():17. PubMed ID: 26979152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV-1 protease substitution K55R: a protease-inhibitor-associated substitution involved in restoring viral replication.
    Margerison ES; Maguire M; Pillay D; Cane P; Elston RC
    J Antimicrob Chemother; 2008 Apr; 61(4):786-91. PubMed ID: 18252693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the temperature-sensitive murine cytomegalovirus (MCMV) mutants tsm5 and tsm30: a study of genes involved in immune evasion, DNA packaging and processing, and DNA replication.
    Sweet C; Ball K; Morley PJ; Guilfoyle K; Kirby M
    J Med Virol; 2007 Mar; 79(3):285-99. PubMed ID: 17245727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of capsid sequence and immature nucleocapsid proteins p9 and p15 in Human Immunodeficiency Virus type 1 genomic RNA dimerization.
    Kafaie J; Dolatshahi M; Ajamian L; Song R; Mouland AJ; Rouiller I; Laughrea M
    Virology; 2009 Mar; 385(1):233-44. PubMed ID: 19070880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of HIV-1 uncoating in human microglial cell lines.
    Ingram Z; Taylor M; Okland G; Martin R; Hulme AE
    Virol J; 2020 Mar; 17(1):31. PubMed ID: 32143686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of monocyte to HIV-1 infection is not due to uncoating defect.
    Srichatrapimuk S; Auewarakul P
    Virus Res; 2007 Jun; 126(1-2):277-81. PubMed ID: 17399836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of human immunodeficiency virus type 1 capsid protein at serine 16, required for peptidyl-prolyl isomerase-dependent uncoating, is mediated by virion-incorporated extracellular signal-regulated kinase 2.
    Dochi T; Nakano T; Inoue M; Takamune N; Shoji S; Sano K; Misumi S
    J Gen Virol; 2014 May; 95(Pt 5):1156-1166. PubMed ID: 24509437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the HIV-1 capsid by MELK triggers uncoating to promote viral cDNA synthesis.
    Takeuchi H; Saito H; Noda T; Miyamoto T; Yoshinaga T; Terahara K; Ishii H; Tsunetsugu-Yokota Y; Yamaoka S
    PLoS Pathog; 2017 Jul; 13(7):e1006441. PubMed ID: 28683086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.